Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: Immunohistochemical and RT-PCR studies

Citation
J. Akahira et al., Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: Immunohistochemical and RT-PCR studies, BR J CANC, 83(11), 2000, pp. 1488-1494
Citations number
59
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
83
Issue
11
Year of publication
2000
Pages
1488 - 1494
Database
ISI
SICI code
0007-0920(200012)83:11<1488:PRIAAB>2.0.ZU;2-A
Abstract
Human epithelial ovarian carcinoma is well-known as a sex steroid-dependent neoplasm, but the possible biological significance of progesterone recepto r (PR) in this cancer remains controversial. Recently, two isoforms of huma n PR, PRA and PRE, have been characterized and different functional charact eristics have been reported for these two isoforms. We therefore examined i mmunohistochemistry (107 cases) and reverse transcription-polymerase chain reaction (RT-PGR) (16 cases) for PRA, PRE, and oestrogen receptor-a (ER-a). Labeling indices (LI) for PRA and PRE were 2.4 and 43.6, respectively, and the difference was statistically significant. PRE LI, but not PRA LI, as w ell as performance status, stage, and residual tumour turned out to be inde pendent prognostic factors following multivariate analysis. There was also a significant correlation between ER-a LI and PRE LI (r = 0.595, P < 0.0001 ), suggestive of a possible interaction between these two receptors. RT-PGR also detected the expression of PR isoform transcripts in the same pattern as was observed with immunohistochemistry. Results of these studies indica te that PRA and PRE both mediate distinct pathways of progesterone action i n ovarian carcinoma. Moreover, it is important to examine PRE tl as a progn ostic factor in the cases of human epithelial ovarian carcinoma. (C) 2000 C ancer Research Campaign http://www.bjcancer.com.